Todd Wallach

Todd Wallach is an experienced business leader and entrepreneur with a diverse background in biotechnology, pharmaceuticals, medical devices, and space technology. He currently serves as the CEO of SOLUtion Medical, a specialty pharmaceutical company focused on developing innovative drug delivery solutions.123

Professional Experience

Todd Wallach has over 30 years of experience in various leadership roles.4 His current positions include:

• CEO of SOLUtion Medical
• CEO of OncoSTING
• Entrepreneur in Residence at Delaware Innovation Space and the University of Colorado Boulder

Previously, he has held several notable positions:

• Chief Technology Officer at Moon Mark
• President and CEO of Evogen, Inc. and Cognizance Biomarkers, LLC
• CEO and Chairman of Molecular Detection, Inc.
• Chief Financial Officer at Aton Pharma, Inc.
• Vice President of Finance & Operations at Acuity Pharmaceuticals

Education

Todd Wallach has a strong educational background:

• Bachelor of Science in Mechanical Engineering from Purdue University (1983-1986)
• MBA in Management and Finance from Rider University (1986-1991)
• Master of Science in Management of Technology from the University of Pennsylvania's Wharton School of Business and School of Engineering and Applied Science (1998-2000)
• Master's degree in Biotechnology from the University of Pennsylvania (2002)

Achievements and Affiliations

Throughout his career, Todd Wallach has demonstrated significant accomplishments:

• Successfully raised over $75 million in capital and $2 million in grant funding for innovative companies4
• Member of The Explorers Club
• Associate Editor of the Journal of Translational Medicine
• Member of the investment committee of Ben Franklin Technology Partners of Southeastern Pennsylvania
• Participated in the NIH I-Corp Program

At SOLUtion Medical, Todd leads a company that is developing advanced drug delivery systems, including the Valve Technology System (VTS) for pre-filled syringes and the TwistJECT™ auto-injector.3 These innovations aim to simplify treatment processes and improve patient outcomes, particularly in areas such as adrenal crisis management.